Often copied, never equaled – NobelActive® celebrates 10+ years of clinical experience with an abundance of evidence.
The advent of NobelActive represented a major breakthrough in implant design. Today, over a decade later, a wealth of evidence proves it to be a triumph of applied biotechnology.
Chris Kendall, Assistant Editor, Nobel Biocare News
It is the leading, most prominent implant solution in Nobel Biocare’s extensive and diverse range of implants. Its name: NobelActive.
To date, 42 clinical studies have evaluated over 14,300 NobelActive implants involving over 2,600 patients—and this count only includes studies that examined a minimum of ten NobelActive implants followed-up for more than one-year.
Count on good primary stability
The infographic highlights just a few of the many studies that have shown NobelActive can accomplish good primary stability in demanding situations.
The reverse-cutting flutes with drilling blades on the apex enable the adjustment of the implant position during placement for an optimized restorative orientation, particularly in extraction sites.
Furthermore, internal conical connection with hexagonal interlocking offers high mechanical strength. Given such applicability, NobelActive’s mean implant survival rate of 98.5%—in studies with up to, and including, 5 years of follow-up—is all the more impressive.
Count on excellent esthetics
Studies show that NobelActive preserves the critical marginal bone and soft tissue over time for natural-looking esthetics. Its back-tapered collar—together with a strong conical connection and built-in platform shifting—can aid crestal-bone and soft-tissue preservation.
In the end, of course, it’s all about the final results; and in terms of esthetics, self-esteem, speech, sense, and function, patients treated with NobelActive implants have given high marks to its use from pre-treatment, to prosthetic delivery, all the way through three-year follow-up.
This article is a reprint from Nobel Biocare News, Volume 20, Number 1, 2018. © Nobel Biocare Services AG, 2018. Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. In order to improve readability, Nobel Biocare does not use TM/® in the running text. Nobel Biocare does not waive any right to the trademark or registered mark and nothing herein shall be construed to the contrary. Please refer to nobelbiocare.com/trademarks for more information. Product images are not necessarily to scale. Please contact the local Nobel Biocare sales office for current product assortment and availability.